Vokem-GM1

BRAND NAME : Vokem-GM1

COMPOSITION : Voglibose IP 0.2 Mg + Metformin Hcl IP 500 Mg (Sustained Release) + Glimepiride IP 1 Mg

PACKING : 10X10TABS (Blister Pack)

MRP : 97.90/-

Description

INDICATIONS :

Glimepiride + Metformin + Voglibose 1 Mg/500 Mg/0.2 Mg Tablet SR belongs to a category of medicines known as anti-diabetic drugs.

USES :

Glimepiride, metformin and voglibose. They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas to lower the blood glucose. Metformin is a biguanide which lowers glucose production in the liver, delays glucose absorption from intestines and increases the body’s sensitivity to insulin. Voglibose is an alpha-glucosidase inhibitor which prevents breakdown of complex sugars into simple sugars such as glucose. This prevents the blood glucose levels from rising to very high levels after meals.

SIDE EFFECTS :

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level).
Vokem-GM1
Scroll to top